TITAN PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
TITAN PHARMACEUTICALS INC has filed 1,052 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 376-400 of 686 matching filings.

Per page
25
Current page
16
CT ORDER File 001-13341

CT ORDER filing

Filing date
15 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

8-K

Filing date
01 Jun 2018
Reporting date
29 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
30 May 2018
Reporting date
25 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
23 May 2018
Reporting date
14 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
16 May 2018
Reporting date
14 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
13 Apr 2018
Reporting date
09 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-13341

CT ORDER filing

Filing date
02 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
26 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-46083

SC 13G/A

Filing date
08 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
07 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

8-K

Filing date
22 Jan 2018
Reporting date
22 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-13341

CT ORDER filing

Filing date
07 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
28 Nov 2017
Reporting date
27 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221126

EFFECT filing

Filing date
08 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-221126

S-3/A

Filing date
06 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-221126

S-3

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

8-K

Filing date
12 Oct 2017
Reporting date
11 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

8-K

Filing date
02 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .